Nephropathy in the Wiskott-Aldrich syndrome

L. E. Spitler, Betty Beasley Wray, S. Mogerman, J. J. Miller IIIrd, R. J. O'Reilly, M. Lagios

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Nephropathy was detected in 5 of 32 patients with the Wiskott-Aldrich syndrome who were participating in a study of transfer factor (TF) therapy. In two patients, nephropathy was present before TF and did not appear changed by TF therapy. One of these patients subsequently developed progressive renal failure requiring dialysis beginning 5 1/2 years after TF therapy. In 2 patients, decreased renal function appeared very soon after the administration of TF. One patient showed gradually decreasing renal function beginning after 2 years of TF therapy. An additional patient was identified who died with renal failure without having received TF. The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome.

Original languageEnglish (US)
Pages (from-to)391-398
Number of pages8
JournalPediatrics
Volume66
Issue number3
StatePublished - Dec 1 1980
Externally publishedYes

Fingerprint

Wiskott-Aldrich Syndrome
Transfer Factor
Renal Insufficiency
Kidney
Therapeutics
Dialysis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Spitler, L. E., Wray, B. B., Mogerman, S., Miller IIIrd, J. J., O'Reilly, R. J., & Lagios, M. (1980). Nephropathy in the Wiskott-Aldrich syndrome. Pediatrics, 66(3), 391-398.

Nephropathy in the Wiskott-Aldrich syndrome. / Spitler, L. E.; Wray, Betty Beasley; Mogerman, S.; Miller IIIrd, J. J.; O'Reilly, R. J.; Lagios, M.

In: Pediatrics, Vol. 66, No. 3, 01.12.1980, p. 391-398.

Research output: Contribution to journalArticle

Spitler, LE, Wray, BB, Mogerman, S, Miller IIIrd, JJ, O'Reilly, RJ & Lagios, M 1980, 'Nephropathy in the Wiskott-Aldrich syndrome', Pediatrics, vol. 66, no. 3, pp. 391-398.
Spitler LE, Wray BB, Mogerman S, Miller IIIrd JJ, O'Reilly RJ, Lagios M. Nephropathy in the Wiskott-Aldrich syndrome. Pediatrics. 1980 Dec 1;66(3):391-398.
Spitler, L. E. ; Wray, Betty Beasley ; Mogerman, S. ; Miller IIIrd, J. J. ; O'Reilly, R. J. ; Lagios, M. / Nephropathy in the Wiskott-Aldrich syndrome. In: Pediatrics. 1980 ; Vol. 66, No. 3. pp. 391-398.
@article{5ab9086395274eb0bbd7a8bda1e0c957,
title = "Nephropathy in the Wiskott-Aldrich syndrome",
abstract = "Nephropathy was detected in 5 of 32 patients with the Wiskott-Aldrich syndrome who were participating in a study of transfer factor (TF) therapy. In two patients, nephropathy was present before TF and did not appear changed by TF therapy. One of these patients subsequently developed progressive renal failure requiring dialysis beginning 5 1/2 years after TF therapy. In 2 patients, decreased renal function appeared very soon after the administration of TF. One patient showed gradually decreasing renal function beginning after 2 years of TF therapy. An additional patient was identified who died with renal failure without having received TF. The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome.",
author = "Spitler, {L. E.} and Wray, {Betty Beasley} and S. Mogerman and {Miller IIIrd}, {J. J.} and O'Reilly, {R. J.} and M. Lagios",
year = "1980",
month = "12",
day = "1",
language = "English (US)",
volume = "66",
pages = "391--398",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Nephropathy in the Wiskott-Aldrich syndrome

AU - Spitler, L. E.

AU - Wray, Betty Beasley

AU - Mogerman, S.

AU - Miller IIIrd, J. J.

AU - O'Reilly, R. J.

AU - Lagios, M.

PY - 1980/12/1

Y1 - 1980/12/1

N2 - Nephropathy was detected in 5 of 32 patients with the Wiskott-Aldrich syndrome who were participating in a study of transfer factor (TF) therapy. In two patients, nephropathy was present before TF and did not appear changed by TF therapy. One of these patients subsequently developed progressive renal failure requiring dialysis beginning 5 1/2 years after TF therapy. In 2 patients, decreased renal function appeared very soon after the administration of TF. One patient showed gradually decreasing renal function beginning after 2 years of TF therapy. An additional patient was identified who died with renal failure without having received TF. The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome.

AB - Nephropathy was detected in 5 of 32 patients with the Wiskott-Aldrich syndrome who were participating in a study of transfer factor (TF) therapy. In two patients, nephropathy was present before TF and did not appear changed by TF therapy. One of these patients subsequently developed progressive renal failure requiring dialysis beginning 5 1/2 years after TF therapy. In 2 patients, decreased renal function appeared very soon after the administration of TF. One patient showed gradually decreasing renal function beginning after 2 years of TF therapy. An additional patient was identified who died with renal failure without having received TF. The results suggest that renal failure occurs in the Wiskott-Aldrich syndrome more frequently than generally recognized and that administration of TF may precipitate or accelerate the renal disease in patients with this syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0018971205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018971205&partnerID=8YFLogxK

M3 - Article

C2 - 7422429

AN - SCOPUS:0018971205

VL - 66

SP - 391

EP - 398

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -